Skip to content

Clavipectoral Block Versus Interscalene Block for Postoperative Analgesia in Midshaft Clavicular Surgery

Ultrasound-guided Clavipectoral Fascia Plane Block Versus Interscalene Brachial Plexus Block for Postoperative Analgesia in Midshaft Clavicular Surgery

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06917820
Enrollment
50
Registered
2025-04-09
Start date
2025-05-01
Completion date
2026-03-14
Last updated
2026-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Pain

Brief summary

The aim of this study is to compare between (ISBPB) and (CPB) as postoperative analgesic technique following midshaft clavicular fracture open reduction and internal fixation surgeries.

Detailed description

The aim of this study is to compare between (ISBPB) and (CPB) as postoperative analgesic technique following midshaft clavicular fracture open reduction and internal fixation surgeries. Preoperative full precise medical history will be taken from patients. Routine investigations will be done to all patients including ECG and laboratory investigations as CBC, AST, ALT, INR, PT and PTT. Demographic data as age and weight will be recorded. All patients will be consented for every anesthetic and surgical procedure to be done. Base line diaphragmatic excursion will be assessed in all patients in the induction room using a curvilinear low-frequency ultrasound probe (2-5 MHz; SonoSite Inc., Bothell, WA, USA), in supine position. The diaphragmatic excursion measurement will be performed on the hemidiaphragm at the same side of the study block. Excursion amplitude will be defined as the craniocaudal perpendicular distance from the minimum to the maximum point of diaphragm excursion. Diaphragmatic excursion measurements will be performed before induction of general anesthesia and performing the block technique and at 3 hours after the block or 1 hour after recovery from anesthesia if the surgery lasted more than 2 hours. Then, for all patients, on arrival to the operating room, ECG, heart rate (HR), non-invasive blood pressure, and pulse oximetry will be monitored. Patients will receive 0.03 mg/kg of IV midazolam and 3 L/ min nasal oxygen. After that, induction of GA will be performed by injecting intravenous (IV) 1 mcg/kg fentanyl, 2 mg/kg propofol and 0.5 mg/kg atracurium. Then, the patients will receive one of the study blocks as following: Group A: This group will receive ultrasound-guided clavipectoral fascia plane block. Group B: This group will receive ultrasound-guided interscalene plexus block.

Interventions

PROCEDUREInterscalene brachial plexus block

Ultrasound-guided peripheral nerve block that includes injection of local anesthetics between the C5 and C6 nerve roots and between C6 and C7 nerve roots.

PROCEDUREClavipectoral fascia plane block

Ultrasound-guided peripheral nerve block that includes injection of local anesthetics between the periosteum of clavicle and the surrounding clavipectoral fascia.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged from 21 to 60 years. * American Society of Anesthesiologists (ASA) class I and II status. * Of both sexes. * Patients undergoing elective midshaft clavicle fracture open reduction and internal fixation surgery.

Exclusion criteria

* Patient refusal. * American Society of Anesthesiologists (ASA) class llI and IV status. * Patients with bleeding disorders. * A history of relevant drug allergy to any of the used drugs. * Alcohol or drug abuse and opioid dependence. * Pregnant female patients. * Patients with BMI above 35 kg/m2. * Patients with infection at site of the fracture or the block procedure. * Patients with reduced pulmonary functions due to chronic obstructive pulmonary disease (COPD), uncontrolled asthma, pneumothorax or pleural effusion.

Design outcomes

Primary

MeasureTime frameDescription
Time to first rescue analgesia24 hours after injectionThe time to first rescue analgesia with time frame of 24 hours after the study block will be recorded.
Rescue analgesia consumed24 hours after injectionThe total dose of rescue analgesia consumed within 24 hours after the block will be recorded.

Secondary

MeasureTime frameDescription
Incidence of hemi-diaphragmatic paresis3 hours after block or 1 hour after recovery from anesthesia.The incidence of hemi-diaphragmatic paresis at 3 hours after block or 1 hour after recovery from anesthesia if the surgery lasted more than 2 hours. Hemi-diaphragmatic paresis will be defined as greater than 50% reduction in diaphragmatic excursion compared with the pre block value during deep breathing.
Visual analogue scale (VAS)24 hours after injectionThe VAS is psychometric measuring instrument designed to document the disease-related symptom severity in individual patients. It will be recorded at 4-hour intervals. A VAS score of 4 or more will be treated with pethidine 50 mg IM as rescue analgesia to be repeated if needed provided that the total 24-hour dosage will not exceed 150 mg.
Heart rate24 hours after injectionThe heart rate of patients will be recorded at baseline just after the block and at the same intervals as the VAS.
Mean arterial blood pressure24 hours after injection.The mean arterial blood pressure of patients will be recorded at baseline just after the block and at the same intervals as the VAS.
Motor function of the relevant upper limb3 hours after block or 1 hour after recovery from anesthesia.Motor function of the relevant upper limb will be evaluated before induction of general anesthesia and performing the block technique and at 3 hours after the block or 1 hour after recovery from anesthesia if the surgery lasted more than 2 hours in the distribution of the axillary nerve (shoulder abduction), musculocutaneous nerve (elbow flexion), radial nerve (wrist extension), median nerve (wrist flexion), and ulnar nerve (thumb/finger adduction) using a 3-point scale (0 = normal strength, 1 = paresis, or 2 = paralysis), with maximal total motor block score of 10.
Other complications24 hours after injectionComplications like postoperative nausea and vomiting, Horner's syndrome and pneumothorax will be recorded.

Countries

Egypt

Contacts

STUDY_DIRECTORMoustafa K Reyad, Professor

Ain Shams University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 14, 2026